首页> 外文期刊>American journal of cardiovascular drugs: drugs, devices, and other interventions >Endovascular stents: A review of their use in peripheral arterial disease
【24h】

Endovascular stents: A review of their use in peripheral arterial disease

机译:血管内支架:其在外周动脉疾病中的应用综述

获取原文
获取原文并翻译 | 示例
           

摘要

Technological advances in the past decade have shifted revascularization strategies from traditional open surgical approaches toward lower-morbidity percutaneous endovascular treatments for patients with lower extremity peripheral arterial disease (PAD). The continuing advances in stent design, more than any other advances, have fueled the growth of catheter-based procedures by improving the safety, durability, and predictability of percutaneous revascularization. Although the 2007 TransAtlantic Inter-Society Consensus (TASC) guidelines recommend endovascular therapy for type A and B aortoiliac and femoropopliteal lesions, recent developments in stent technology and increased experience of interventionists have suggested that a strategy of endovascular therapy first is appropriate in experienced hands for TASC type D lesions. The role of endovascular interventions is also expanding in the treatment of limb-threatening ischemia.
机译:在过去的十年中,技术的进步已将血运重建策略从传统的开放式手术方法转移到了下肢周围动脉疾病(PAD)患者的低发病率经皮血管内治疗。支架设计的持续进步,比其他任何进步,都通过提高安全性,耐用性和经皮血运重建的可预测性推动了基于导管的手术的发展。尽管2007年《跨大西洋社会间共识》(TASC)指南建议对A型和B型主动脉和股pop皮病变进行血管内治疗,但是支架技术的最新发展和介入医师的丰富经验表明,对于有经验的人,首先应采用血管内治疗策略TASC D型病变。血管内干预的作用在肢体威胁性缺血的治疗中也正在扩大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号